Printer Friendly
The Free Library
22,728,043 articles and books

Browse Drug approval topic

 

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
GSK and Genmab receive FDA approval for Arzerra (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate. Apr 17, 2014 2743
The Zacks Analyst Blog Highlights:GIlead, AbbVie, MannKind, Alkermes and Pharmacyclics. Apr 17, 2014 2159
Volasertib, Boehringer Ingelheim's Investigational Oncology Compound, is Granted Orphan Drug Designation for Acute Myeloid Leukemia in the U.S. and EU. Apr 17, 2014 1145
Dr. Victor Lacombe is Excited to Announce That the FDA Approved New CoolSculpting Applicator for Outer Thigh Fat. Apr 16, 2014 157
Mylan Launches First Generic ORTHO EVRA Patch. Apr 16, 2014 463
Mylan Launches Generic Lunesta Tablets. Company overview Apr 15, 2014 365
30-Year Ultra Long Gilt Futures Updates, Partnerships, Notes Offer Pricings, and Drug Approvals - Analyst Notes on IntercontinentalExchange, Western Union, Essex Property , Valeant and Pharmacyclics. Apr 15, 2014 1384
Depomed Announces Settlements with Two Gralise ANDA Filers. Apr 14, 2014 585
Healthcare Companies Report Product Availability, Earning Release Schedules, Event, and Stock Movements - Analyst Notes on Celgene, Vanda, Chelsea Therapeutics, Neurocrine Biosciences, and USANA. Apr 14, 2014 1445
Boehringer Ingelheim and Eli Lilly and Company Announce New Drug Application Filing in the U.S. for the Combination Tablet of Empagliflozin and Linagliptin. Apr 14, 2014 2059
ReCept Pharmacy to Distribute Otezla (apremilast): The First FDA Approved Oral Medication for the Treatment of Psoriatic Arthritis for Adults. Apr 14, 2014 425
Belgium : EUROPEAN COMMISSION approves of a joint procurement agreement. Apr 14, 2014 259
Let's Get the Facts Straight About Zohydro(TM) ER--and the Important Patient Need It Fills. Apr 11, 2014 2581
FDA Approves Lipiodol (Ethiodized Oil) Injection for Imaging of Tumors in Adults with Known Hepatocellular Carcinoma (HCC). Apr 10, 2014 1281
The Zacks Analyst Blog Highlights:MannKind, Cubist, Medicines Co., Amgen and Halozyme. Apr 10, 2014 2111
United States : Supplemental New Drug Application for IMBRUVICA (ibrutinib) Submitted to the U.S. FDA. Apr 9, 2014 428
Waismann Method: Prescription painkiller/heroin overdose antidote approved by FDA. Apr 8, 2014 744
Updated with Multimedia Content: FDA Approves Pradaxa (dabigatran etexilate mesylate) for Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism. Apr 8, 2014 3185
Zogenix Update on Legal Action. Apr 8, 2014 1028
Nexcyon Achieves European Regulatory Decision. Apr 7, 2014 648
FDA Approves Pradaxa (dabigatran etexilate mesylate) for Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism. Apr 7, 2014 3114
Nexcyon Achieves European Regulatory Decision. Apr 7, 2014 451
Par Pharmaceutical Begins Shipment of Potassium Chloride Extended-Release Capsules. Apr 7, 2014 355
United States : FDA approves new hand-held auto-injector to reverse opioid overdose. Apr 4, 2014 452
United States : PACIRA PHARMA gets US FDA approval for an additional manufacturing suite for EXPAREL. Apr 4, 2014 150
U.S. Food and Drug Administration Approves Kaleo's EVZIO(TM) for the Emergency Treatment of Opioid Overdose. Apr 3, 2014 2134
United States : FDA approves first sublingual allergen extract for the treatment of certain grass pollen allergies. Apr 3, 2014 446
FDA APPROVES XOLAIR FOR PEOPLE WITH CIU. Apr 1, 2014 579
Japan : Takeda Announces the New Drug Application Approval of Cell Cultured Influenza vaccine H5N1 "TAKEDA" 1mL and Cell Cultured Influenza vaccine (Prototype) "TAKEDA" 1mL in Japan for Prevention of. Apr 1, 2014 293
Janssen Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat as Part of Combination HIV Therapy. Apr 1, 2014 2061
Germany : Bayer s Adempas (riociguat) Approved for the Treatment of Two Life-Threatening Forms of Pulmonary Hypertension in the EU. Apr 1, 2014 440
United States : FDA approves first long-acting recombinant coagulation Factor IX concentrate for patients with Hemophilia B. Mar 29, 2014 307
Healthcare Companies Make Presentations, Submissions, Investigation Extensions, and Expansions - Analyst Notes on CR Bard, Medivation, Align Technology, Covance, and PAREXEL. Mar 28, 2014 1585
Investigation Report on China Pemetrexed Market, 2009-2018. Mar 28, 2014 715
Investigation Report on China Pemetrexed Market, 2009-2018. Mar 28, 2014 663
Taiwan Province of China,United States : TAIWAN cancer drug gets approval from FDA for clinical trials. Mar 28, 2014 172
Duchesnay USA Granted Kosher and Halal Certification for Diclegis (doxylamine succinate and pyridoxine hydrochloride), the Only FDA-Approved Treatment for Nausea and Vomiting of Pregnancy (NVP). Mar 27, 2014 1030
Drug Approvals, Stock Price Movements, and New Tools for Standardization - Analyst Notes on Biogen Idec, Alexion, Actavis, Thermo Fisher Scientific, and Medtronic. Mar 26, 2014 1451
Large Volume Injection Devices for Self-Administration. Mar 26, 2014 697
Large Volume Injection Devices for Self-Administration. Mar 26, 2014 691
Japan : Takeda Announces the New Drug Application Approval of TAKELDAA Combination Tablets, the Fixed Dose Combination of TAKEPRONA and Low-Dose Aspirin, in Japan. Mar 26, 2014 259
Japan : Takeda Announces the New Drug Application Approval of ZacrasA Combination Tablets LD and ZacrasA Combination Tablets HD in Japan for the Treatment of Hypertension. Mar 26, 2014 367
United States : US FDA grants approval to NOVARTIS for XOLAIR. Mar 26, 2014 126
United States : Drug Developers Drawn to Orphan Drugs Market: Financial Incentives Create Rich, Competitive Pipelines. Mar 26, 2014 388
Drug Developers Drawn to Orphan Drugs Market: Financial Incentives Create Rich, Competitive Pipelines. Mar 25, 2014 1137
Drug Developers Drawn to Orphan Drugs Market: Financial Incentives Create Rich, Competitive Pipelines. Mar 25, 2014 1135
New drug is lifeline for cancer sufferers. Mar 25, 2014 408
United States : BURMAN's launches new version of HEALTHTRAC. Mar 25, 2014 217
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%. Mar 25, 2014 1694
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%. Mar 25, 2014 1450
FDA approves oral drug for psoriatic arthritis. Mar 25, 2014 655
United States : FDA approves Otezla to treat psoriatic arthritis. Mar 22, 2014 373
FDA Approvals, Financial Highlights, Restated Treatment Indications, and Updates on Product Pipelines - Analyst Notes on Bristol-Myers Squibb, Galena, Teleflex, GW Pharmaceuticals, and CytRx. Mar 21, 2014 1678
Novartis Announces FDA Approval of Xolair (omalizumab) for Chronic Idiopathic Urticaria (CIU), a Form of Chronic Hives. Mar 21, 2014 2844
Healthcare Companies Report FDA Approvals, Comprehensive Analysis, Schedules, and Stock Movements - Analyst Notes on Pfizer, Johnson & Johnson, Biogen, Express Scripts, and Forest Laboratories. Mar 20, 2014 1493
FDA Approves Piramal Imaging's Neuraceq(TM) (florbetaben F18 injection) for PET Imaging of Beta-Amyloid Neuritic Plaques in the Brain. Mar 20, 2014 1333
Japan : Astellas and medivation submit supplemental new drug application for XTANDI (Enzalutamide) for chemotherapy-Naive advanced prostate cancer. Mar 20, 2014 216
United States : FDA approves Impavido to treat tropical disease leishmaniasis. Mar 20, 2014 403
Charity demands prostate cancer drug is approved. Mar 19, 2014 284
Ferring Pharmaceuticals Inc. Receives FDA Approval for the First and Only Mixed Protocol IVF Treatment -- Combines MENOPUR (menotropins for injection) and BRAVELLE (urofollitropin for injection, purified) in Single Syringe. Mar 19, 2014 1065
Children Dying While FDA Stalls on New Muscular Dystrophy Drug; Parents Seek 100,000 Signatures to Get White House's Attention. Mar 19, 2014 527
FDA Approvals, Definitve Agreements, Prestigious Recognitions, and Stock Summaries - Analyst Notes on Mallinckrodt, Novo Nordisk, Charles River Laboratories, Cerner, and Quintiles. Mar 18, 2014 1615
Spain,United States : CROWN HOLDINGS gets approval from European Commission to attain MIVISA. Mar 18, 2014 125
Edison Pharmaceuticals Announces Initiation of EPI-743 Pearson Syndrome Clinical Trial. Mar 17, 2014 680
Star Scientific Files Annual Report for 2013; Reports on Ongoing Corporate Transition and Completion of $15.1 Million Financing. Mar 17, 2014 853
United States : ANGIODYNAMICS wins FDA approval. Mar 14, 2014 205
TaiGen Biotechnology Receives Marketing Approval from the Taiwan Food and Drug Administration for Taigexyn(R) (nemonoxacin) in Taiwan. Mar 13, 2014 700
Product and Pipeline Assessment of the Global Orphan Drugs Market. Mar 13, 2014 1617
Survey Shows 3 out of 4 Women in the U.S. (ages 18-65) Think the Length, Thickness, or Color of Their Eyelashes is Inadequate(1). Mar 13, 2014 2217
Provectus Pharmaceuticals, Inc. Melanoma Version of PV-10 Completes Phase 2 and is Prepping for BTD. Mar 13, 2014 811
Amerigen Pharmaceuticals Limited announces that its ANDA for carbidopa 25mg tablets has received final approval from the U.S. Food and Drug Administration. Mar 12, 2014 313
Upsher-Smith Receives FDA Approval For Qudexy(TM) XR (Topiramate) Extended-Release Capsules. Mar 12, 2014 2305
IGI Laboratories, Inc. Announces First ANDA Approval. Mar 12, 2014 607
Mylan Launches Naloxone Hydrochloride Injection. Company overview Mar 11, 2014 424
THE MEDICINES COMPANY SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against THE MEDICINES COMPANY and Its Board of Directors and a Lead Plaintiff Deadline of April 22, 2014 -- MDCO. Mar 11, 2014 423
Testosterone Lawsuit News: Bernstein Liebhard LLP Notes FDA Approval of New Testosterone Therapy Medication. Mar 7, 2014 748
SIRTURO (bedaquiline) Receives Conditional Approval in the European Union for the Treatment of Multi-Drug Resistant Tuberculosis. Mar 6, 2014 1901
Veloxis Pharmaceuticals publishes Annual Report 2013. Mar 5, 2014 6673
U.S. Food and Drug Administration Issues Complete Response Letter for Empagliflozin. Mar 5, 2014 1203
United States : COVIDIEN's PURITAN BENNET 980 ventilator wins FDA 510(k) approval. Mar 5, 2014 173
The Zacks Analyst Blog Highlights:Actavis, Sanofi, Takeda Pharmaceutical, Forest Laboratories and Iconix Brand Group. Mar 4, 2014 2231
'The Race to Yes' Seeks 100K White House Petition Signatures for Duchenne Therapy. Mar 4, 2014 561
United Kingdom : US FDA approves ASTRAZENECA s injectable treatment for type 2 diabetes. Mar 4, 2014 141
United States : US FDA approves BydureonA Pen (exenatide extended-release for injectable suspension) for once-weekly treatment of adults with type 2 diabetes. Mar 4, 2014 424
Recruitment services for scanning of drug dossiers. Mar 3, 2014 456
Attention The Medicines Company Investors: The Medicines Company Misled Investors According to a Recently Filed Class Action. Mar 3, 2014 605
IGI Laboratories, Inc. Announces Fourteenth ANDA Submission. Mar 3, 2014 536
New painkiller pill set to kill people as soon as it hits shelves! Mar 1, 2014 162
Oasmia Receives FDA Conditional Approval for Its Lead Product Paccal Vet CA-1. Feb 28, 2014 429
Actavis Confirms Generic Multaq Patent Challenge. Feb 28, 2014 909
Actavis Confirms Generic Colcrys Patent Challenge. Feb 28, 2014 870
Provectus Pharmaceuticals, Inc. Melanoma Version of PV-10 Completes Phase 2 and is Prepping for BTD. Feb 27, 2014 833
Mirvaso (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission. Feb 26, 2014 946
Mirvaso (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission. Feb 26, 2014 950
United States : FDA approves Myalept to treat rare metabolic disease. Feb 26, 2014 421
United States : US FDA approves orphan drug MYALEPT (metreleptin for injection). Feb 26, 2014 408
Purchase of drugs hold for pharmacy, public tender no. 01 resolution approval of bases of 10/01/2014 no. 08, application for pharmacy warehouse manager with v b administrative assistant. Id. Public. Feb 26, 2014 110
United States : Pfizer Announces FDA Approval To Include Radiographic Data On Reduction Of Progression Of Structural Joint Damage For Adults With Moderately To Severely Active Rheumatoid Arthritis In. Feb 25, 2014 445
Auxilium Pharmaceuticals, Inc. Announces The FDA Acceptance Of Application Requesting Approval Of XIAFLEX For The Concurrent Treatment Of Multiple Palpable Cords. Feb 24, 2014 1668
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against The Medicines Company. Feb 24, 2014 790
European Commission approves state aid for Marseille Provence airport. Feb 24, 2014 127
MAPS: Public Health Service Blocks FDA-Approved Medical Marijuana Research For Veterans With PTSD. Feb 21, 2014 491
United States : FDA approves Northera to treat neurogenic orthostatic hypotension. Feb 20, 2014 421
Proposed Asthma Inhaler Puts Patients at Risk. Feb 19, 2014 482
Guerbet Receives FDA Approval for a New Manufacturing Plant for Lipiodol (ethiodized oil) Injection. Feb 19, 2014 1169
United Kingdom,United States : SHIRE PLC obtains FDA approval to produce Vpriv Drug substance. Feb 18, 2014 217
United States : USFDA approves SHIRE to produce VPRIV drug substance at MASSACHUSETTS unit. Feb 18, 2014 211
United Kingdom,United States : SHIRE PLC obtains FDA approval to produce Vpriv Drug substance. Feb 17, 2014 217
European Commission to approve second GMO corn variety. Feb 17, 2014 468
FDA panel: NSAIDs need no new CV warnings. Ault, Alicia Feb 15, 2014 604
United States : FDA approves Vimizim to treat rare congenital enzyme disorder. Feb 15, 2014 373
India : SUN PHARMA receives approval from US FDA Nod for Generic Temodar. Feb 14, 2014 144
Shire Announces FDA Approval of Manufacturing Facility for VPRIV (Velaglucerase Alfa for Injection) Drug Substance. Feb 14, 2014 1292
Shire Announces FDA Approval of Manufacturing Facility for VPRIV (Velaglucerase Alfa for Injection) Drug Substance. Feb 14, 2014 1301
Science Financier Jeffrey Epstein Heralds FDA's Approval of Inhibitor Cocktails for Melanoma. Feb 14, 2014 496
Jury still out on efficacy of weight-loss drugs. Feb 12, 2014 248
U.S. Food and Drug Administration Approves IMBRUVICA(TM) (ibrutinib) as a Single Agent for Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy. Feb 12, 2014 3689
IMBRUVICA(TM) (ibrutinib) Now Approved in the U.S. for Patients with Chronic Lymphocytic Leukemia Who Have Received At Least One Prior Therapy. Feb 12, 2014 3207
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Previously Treated Chronic Lymphocytic Leukemia. Feb 12, 2014 657
National Consumers League and NOW: FDA Delays Approval of First-Ever Drug Treatment for Low Sexual Desire in Women. Feb 11, 2014 1012
Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz(TM) (clozapine, USP) Oral Suspension. Feb 11, 2014 2059
Jazz Pharmaceuticals Announces U.S. Commercial Availability Of Versacloz(TM) (clozapine, USP) Oral Suspension. Feb 11, 2014 2065
Pill-sized camera to see your insides approved by FDA. Feb 10, 2014 126
Top Scientists and Mothers Appeal to Congress for Breakthrough Child-Saving Therapy. Feb 10, 2014 960
United States : FDA approves a new MS treatment developed at WAYNE. Feb 6, 2014 287
Actavis Confirms Generic Treanda Patent Challenge. Feb 4, 2014 865
Multiple Sclerosis -- KOL Insight and Consensus Outlook Modules. Feb 3, 2014 2987
United States : FDA approves Hetlioz: first treatment for non-24 hour sleep-wake disorder in blind individuals. Feb 1, 2014 428
FDA panel rejects rivaroxaban again for ACS. Mechcatie, Elizabeth Feb 1, 2014 546
Genomics: gearing up for the laboratory of the future. Glorikian, Harry Report Feb 1, 2014 1145
Valeant Pharmaceuticals Announces Approval of Retin-A Micro Microsphere 0.08%. Jan 31, 2014 524
B. Braun Receives FDA Approval For Next Generation 1L Intravenous Containers. Jan 31, 2014 694
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit. Jan 31, 2014 757
FDA Approves HETLIOZ(TM) (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake Disorder. Jan 31, 2014 1533
Government of Kyrgyzstan approves anti-drug program. Jan 29, 2014 112
CEL-SCI Corporation Analyst Report. Company overview Jan 27, 2014 804
New National Poll: American Women Object to Societal Gender Inequity Regarding Sexual Satisfaction, Treatment of Sexual Dysfunction. Jan 27, 2014 1063
Switzerland : CHMP recommends EU approval of a new formulation of Roche s MabThera for patients with non-Hodgkin lymphoma. Jan 25, 2014 433
Perrigo Receives FDA Final Approval For Generic Equivalent To Prandin. Jan 24, 2014 684
Mylan Launches Generic Prandin Tablets. Company overview Jan 23, 2014 426
Actavis Comments on Notification to Allergan, Inc. of Submission of Application for Restasis. Jan 22, 2014 947
Takeda and Lundbeck Announce Brintellix (vortioxetine) for the Treatment of Major Depressive Disorder in Adults is Now Available in Pharmacies. Jan 21, 2014 2906
United States : European Commission grants marketing authorization for GILEAD s SOVALDI for the treatment of chronic hepatitis C infection. Jan 20, 2014 379
United States : Daiichi Sankyo SUBMITS New Drug APPLICATION to FDA. Jan 20, 2014 202
FDA Advisory Committee Recommends Against Approval of the Use of Oral Anticoagulant XARELTO to Reduce the Risk of Thrombotic Cardiovascular Events in Patients with Acute Coronary Syndrome. Jan 16, 2014 3085
Perrigo Announces FDA Final Approval for Generic Version of Vanos (Fluocinonide) Cream 0.1%. Jan 14, 2014 687
Noven Enters Co-Promotion Agreement with Shionogi for Brisdelle(TM) (Paroxetine) Capsules. Jan 13, 2014 2189
FDA, USDA approve virus used to kill salmonella. Jan 13, 2014 433
United States : FDA approves Mekinist in combination with Tafinlar for advanced melanoma. Jan 11, 2014 439
United States : FARXIGA TABLETS receives approval from FDA. Jan 11, 2014 250
India : ZYDUS CADILA receives approval from FDA to market two drugs. Jan 10, 2014 137
Japan : Daiichi Sankyo Submits SAVAYSA(TM) (edoxaban) Tablets New Drug Application to the U.S. FDA for Once-Daily Use for Stroke Risk Reduction in Atrial Fibrillation and for the Treatment and Prevent. Jan 10, 2014 299
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation, Regarding Approval of Combination Therapy for Advanced Melanoma. Jan 9, 2014 727
United States : FDA gives approval to Actavis plc on ABBREVIATED NEW DRUG APPLICATION. Jan 9, 2014 136
United States : FDA approves Farxiga to treat type 2 diabetes. Jan 9, 2014 436
Daiichi Sankyo Submits SAVAYSA(TM) (edoxaban) Tablets New Drug Application to the U.S. FDA for Once-Daily Use for Stroke Risk Reduction in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism. Jan 8, 2014 1019
Daiichi Sankyo Submits SAVAYSA(TM) (edoxaban) Tablets New Drug Application to the U.S. FDA for Once-Daily Use for Stroke Risk Reduction in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism. Jan 8, 2014 1034
Actavis' Generic Version of Micardis Receives FDA Approval. Jan 8, 2014 827
Orexigen Announces June 10, 2014 PDUFA Action Date for Contrave. Jan 7, 2014 1342
Mylan Launches Generic Detrol LA Capsules. Company overview Jan 7, 2014 379
United States : FDA approves Reb M stevia sweetener. Jan 6, 2014 184
Generex/Antigen Express Announce Database Lock of AE37 Breast Cancer Vaccine Trial. Jan 6, 2014 986
Eisai Announces U.S. Availability of FYCOMPA(TM) (perampanel) CIII an Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy Age 12 and Older. Jan 2, 2014 2058
Global pharma outlook for 2014: Will 2014 finally put an end to the market contraction of the last five years? Chatterjee, Bikash Jan 1, 2014 1776
Last minute? no problem: 3c packaging helps aalpharma make a last minute labelling change. Jan 1, 2014 827
United States : Veloxis Pharmaceuticals SUBMITS NDA to the US FDA. Dec 31, 2013 299
Veloxis Pharmaceuticals Announces NDA Submission for Envarsus in Kidney Transplant Recipients. Dec 30, 2013 848
Healthcare Companies Report Board Changes, FDA Approvals, and Conference Call Schedules - Research Report on Quest Diagnostics, Supernus Pharma, Puma Biotechnology, Pacira, and ResMed. Report Dec 30, 2013 1328
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid. Dec 30, 2013 634
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid. Dec 30, 2013 638
United States : EUROPEAN COMMISSION approves MERCK s Erbitux for cancer treatment. Dec 26, 2013 131
FDA Drug Approvals, Newly Elected Board of Directors, and Stock Price Updates on Healthcare Companies - Research Report on Theravance, Quintiles, Ironwood, Progenics, and Immunomedics. Report Dec 25, 2013 1328
United States : FDA approves Tretten to treat rare genetic clotting disorder. Dec 24, 2013 305
Actavis Confirms Generic NuvaRing Patent Challenge. Dec 24, 2013 928
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors. Dec 23, 2013 1305
European Commission Approves Update of Erbitux Metastatic Colorectal Cancer Labeling to Patients With RAS Wild-Type Tumors. Dec 23, 2013 1308
FDA Approves TRETTEN for the Treatment of Congenital Factor XIII A-Subunit Deficiency. Dec 23, 2013 1074
FDA approves new label indications for Bayer's Advantage Multi (imidacloprid + moxidectin) in the U.S. Dec 20, 2013 1421
Auxilium Pharmaceuticals, Inc. Submits Application To The FDA Requesting Approval Of XIAFLEX For Concurrent Treatment Of Multiple Palpable Cords. Dec 20, 2013 1758
FDA Approves Orenitram(TM) (treprostinil) Extended-Release Tablets for the Treatment of Pulmonary Arterial Hypertension. Dec 20, 2013 1126
United Kingdom : ANORO ELLIPTA approved as first once-daily dual bronchodilator for the treatment of COPD in the US. Dec 19, 2013 446
Has the call to bid less than or equal to public utm 100, and approving administrative and technical basis for procurement of "chronic diseases drugs". Dec 19, 2013 103
SCM Pharma given the go-ahead for US market; MEDICINE. Company overview Dec 19, 2013 482
United States : FDA approves CSL BEHRING's KCENTRA. Dec 17, 2013 175
United States : DELAYED release capsules Duloxetine launched by Citron Pharma. Dec 14, 2013 142
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi. Report Dec 13, 2013 1485
Kcentra, from CSL Behring, Receives FDA Approval for Use in Warfarin Reversal in Patients Undergoing Surgery. Dec 13, 2013 1752
Mauritius : FDA approves 50 million euros LOAN for Mauritius. Dec 12, 2013 155
Dividends, FDA Approved Treatments, Clinical Data Presentations and Completed License Applications - Research Report on Medtronic, Auxilium, Alnylam, Infinity, and Halozyme. Report Dec 11, 2013 1716
Absorption Pharmaceuticals and Kaiser Permanente Initiate Clinical Trial of Promescent. Dec 11, 2013 1058
United States : LUPIN receives USFDA approval for HIV generic drug. Dec 10, 2013 135
Upsher-Smith Presents New Data On The PK Equivalence Of USL255 (Extended-Release Topiramate) When Sprinkled On Food Or Swallowed Intact. Dec 10, 2013 1016
American Liver Foundation Hails Promise of Cure Signaled by FDA's Approval of New Hepatitis C Treatments. Dec 10, 2013 784
FDA Advisory Committee Recommends Approval of Takeda's Investigational Biologic Vedolizumab. Dec 9, 2013 1480
Canada : BIOMARIN Pharmaceutical awaits CANDIAN approval for Vimizim. Dec 7, 2013 186
United States : FDA approves first drug treatment for Peyronie s disease. Dec 7, 2013 453
United States : FDA approves Sovaldi for chronic hepatitis C. Dec 7, 2013 433
Mylan Launches Cabergoline Tablets. Dec 5, 2013 352
Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease. Dec 5, 2013 1574
The Zacks Analyst Blog Highlights: Celgene, Biogen, Gilead, Orexigen and Cubist. Dec 5, 2013 1948
Events, Marketing Recommendation, FDA Meeting, and Marketing Authorization - Research Report on Hospira, Novo Nordisk, Repros Therapeutics, GW Pharmaceuticals, and Envision Healthcare. Report Dec 2, 2013 1593
Bioniche Life Sciences Inc. Horse Product Approved for Sale in the U.S. Dec 1, 2013 943
From the publisher. Collin, Jonathan Dec 1, 2013 1914
GLIOLAN RECEIVES TGA APPROVAL FOR BRAIN TUMOR DRUG. Dec 1, 2013 1015
Lurasidone OK'd for treating bipolar depression. Jancin, Bruce Dec 1, 2013 588
FDA Approvals, Scheduled Presentations, and Stock Price Movements - Research Report on Amgen, St. Jude Medical, Life Technologies, Ligand, and Infinity Pharmaceuticals. Report Nov 29, 2013 1391
Healthcare Companies Report Growth through FDA Approvals, Agreements and Announcements - Research Report on Johnson & Johnson, Stryker, Vertex, Fonar, and Nordion. Report Nov 28, 2013 1398
BTG plc: FDA Approves Varithena(TM) (Polidocanol Injectable Foam) for the Treatment of Patients with Varicose Veins. Nov 26, 2013 952
United Kingdom : H5N1 vaccine approved by the U.S. FDA as pandemic influenza preparedness measure. Nov 26, 2013 396
United Kingdom : FDA Approves GlaxoSmithKlines Bird Flu Vaccine. Nov 25, 2013 301
VIDEO NOW AVAILABLE: OLYSIO(TM) (simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C. Nov 25, 2013 2888
Orexigen Announces Successful Interim Analysis of Contrave Light Study. Nov 25, 2013 1709
FDA Approvals, Public Offerings and Stock Price Movements - Research Report on BioMarin, AEterna Zentaris, Charles River, Anika Therapeutics and Halozyme Therapeutics. Report Nov 25, 2013 1416
Health Ministry approves increase in price of drugs. Nov 23, 2013 179
Belgium : OLYSIO (simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C. Nov 23, 2013 461
U.S. FDA Approves NEXAVAR (sorafenib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory to Radioactive Iodine Treatment. Nov 22, 2013 3531
OLYSIO(TM) (simeprevir) Receives FDA Approval for Combination Treatment of Chronic Hepatitis C. Nov 22, 2013 2823
Court Orders, Stock Price Movements, FDA Approvals and Strategic Collaborations - Research Report on Johnson & Johnson, Santarus, Salix, St. Jude Medical, and Covance. Report Nov 21, 2013 1501
Imprimis Optimistic After Congressional Passage of the Drug Quality and Security Act. Nov 19, 2013 1112
Boston Scientific Receives FDA Clearance And CE Mark Approval For Direxion(TM) Torqueable Microcatheter. Nov 19, 2013 1047
Mylan Launches First Generic Focalin XR Capsules, 30 mg. Nov 18, 2013 400
FDA Approvals, Stock Price Movements, Published Studies, and Philanthropic Initiatives - Research Report on Johnson & Johnson, Express Scripts, Endo, Biogen and Covidien. Report Nov 18, 2013 1480
Antigen Express AE37 Breast Cancer Vaccine Update. Nov 18, 2013 1009
: Bayer Receives Approval for New Cancer Drug Xofigo in the EU. Nov 16, 2013 366
United States : IMBRUVICA (ibrutinib) Capsules Now Approved in the U.S. for Mantle Cell Lymphoma Patients Who Have Received at Least One Prior Therapy. Nov 16, 2013 440
FDA Approves Conceive Plus Fertility Personal Lubricant for US Market Release. Nov 15, 2013 495
WuXi PharmaTech to Partner with Pharmacyclics. Nov 15, 2013 590
Valeant Pharmaceuticals Announces U.S. Approval Of Luzu Cream, 1%. Nov 15, 2013 846
FDA approves extended-release hydrocodone capsules. Fulton, Denise Nov 15, 2013 356
Vanda Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review HETLIOZ(TM) NDA. Nov 14, 2013 201
Actavis Confirms Generic Axiron Patent Challenge. Nov 14, 2013 854
United Kingdom : IMBRUVICA (ibrutinib) Capsules Now Approved in the U.S. for Mantle Cell Lymphoma Patients Who Have Received at Least One Prior Therapy. Nov 14, 2013 441
U.S. Food and Drug Administration Approves IMBRUVICA(TM) (ibrutinib) as a Single Agent for Patients with Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy. Nov 13, 2013 3141
IMBRUVICA(TM) (ibrutinib) Capsules Now Approved in the U.S. for Mantle Cell Lymphoma Patients Who Have Received at Least One Prior Therapy. Reprint Nov 13, 2013 2418
Putney Ranked Number 290 on Deloitte's 2013 Technology Fast 500(TM). Nov 13, 2013 659
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Certain Patients with Mantle Cell Lymphoma. Nov 13, 2013 623
FDA Approval, Quarterly Reports, Event, and Licensing Agreement - Research Report on Novo Nordisk, DexCom, Theravance, PDL, and WuXi PharmaTech. Nov 12, 2013 1525
Mylan Launches Generic Version of Aciphex Tablets. Nov 11, 2013 369
Specialised Therapeutics Australia Receives Therapeutic Goods Administration Approval for Brain Tumour Visualisation Drug - Gliolan(R). Nov 11, 2013 1347
United States : FDA approves first generic versions of Aciphex delayed-release tablets to treat GERD. Nov 9, 2013 383
United States : FDA approves Aptiom to treat seizures in adults. Nov 9, 2013 332
Juvederm Voluma(TM) XC gets FDA Approval! Nov 6, 2013 112
Conference Call Schedules, Presentations, Collaborations and FDA Approvals - Research Report on Pharmacyclics, Pacira Pharmaceuticals, Raptor Pharmaceuticals, Impax Laboratories, and AcelRx. Report Nov 6, 2013 1592
Attention Amarin Corporation plc Investors: Amarin Corporation plc Misled Investors According to a Newly Filed Class Action. Nov 6, 2013 668
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies. Nov 5, 2013 2185
Ventana to partner with Incyte on the development of Companion Diagnostic tests. Nov 5, 2013 533
United States : FDA approves GENENTECH s Gazyva. Nov 4, 2013 130
The Leukemia & Lymphoma Society Applauds FDA's Approval of Gazyva as First-Line Treatment for Patients with Chronic Lymphocytic Leukemia. Nov 4, 2013 512
Epaned, a Liquid Form of Enalapril for Children and Adults with High Blood Pressure, Now Available by Prescription. Nov 4, 2013 2186
Presentation, Quarterly Reports, and FDA Approval - Research Report on Merck, United Therapeutics, Endo, Isis Pharmaceuticals, and Zogenix. Nov 4, 2013 1454
BD Rx Announces FDA Approval of High-Demand Injectable for Pain Management. Nov 4, 2013 2564
IGI Laboratories, Inc. Receives Formal US FDA Approval For Site Transfer Of Econazole Nitrate. Nov 1, 2013 528
IGI Laboratories, Inc. Announces Thirteenth ANDA Submission. Nov 1, 2013 533
US food and drug administration--approved laboratory tests after Caronia. Allen, Timothy Craig Nov 1, 2013 1169
Panel: omega-3 pill needs more CV outcomes data. Mechcatie, Elizabeth Nov 1, 2013 1049
Sun Chemical Receives FDA approval for FCN for C.I. Pigment Red 122. Nov 1, 2013 124
Actavis Confirms Generic Absorica Patent Challenge. Oct 31, 2013 885
Actavis Confirms Generic Acanya Gel Patent Challenge. Oct 28, 2013 1047
New Study Shows Promise For First Effective Medicine To Treat Cocaine Dependence. Report Oct 28, 2013 1152
United States : GE Healthcare Announces FDA Approval of Vizamyl (Flutemetamol F18 Injection) for Detection of Beta Amyloid. Oct 28, 2013 424
Anti-epileptic drug could effectively treat cocaine dependence. Oct 27, 2013 368
United States : Cubist gets US FDA approval for expanded use of Entereg. Oct 26, 2013 341
FDA Approves Addition to CIALIS (tadalafil) Product Label. Oct 25, 2013 2458
Belgium : European Commission welcomes European Parliament's approval of a cash injection of 2.7bn into EU budget. Oct 25, 2013 342
India,United States : LUPIN LIMITED has won FDA approval for its NDA for Antara Capsules. Oct 25, 2013 161
David S. Balle, M.D., the First Physician in Michigan to Correct Age-Related Volume Loss in Cheek area with newly FDA Approved Juvederm Voluma(TM) XC. Oct 25, 2013 540
FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients. Oct 24, 2013 860
Switzerland : Roche gains FDA approval for new subcutaneous formulation of ACTEMRA for use in adult patients living with moderately to severely active rheumatoid arthritis. Oct 23, 2013 266
United Kingdom : ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV. Oct 23, 2013 339
Lupin Receives FDA Approval for its New Drug Application for Antara Capsules. Oct 22, 2013 487
ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV. Oct 22, 2013 2957
Iroko Pharmaceuticals Receives FDA Approval for ZORVOLEX(TM). Oct 21, 2013 1545
United States : ZORVOLEX gets FDA approval. Oct 21, 2013 438
Switzerland,United States : FDA grants approval to ACTELION for hypertension drug. Oct 19, 2013 156
Alimera Sciences Receives Complete Response Letter For ILUVIEN. Oct 18, 2013 1419
Cimzia (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis. Oct 18, 2013 4544
United States : NEW drug to treat depression approved by FDA. Oct 18, 2013 298
Vanda Pharmaceuticals Announces FDA Advisory Committee Meeting On November 14, 2013. Oct 16, 2013 577
United States : ROCHE receives FDA approval for its oncology drug Perjeta to treat breast cancer. Oct 15, 2013 189
Eisai's EMEA Operation Becomes the US Supply Centre for Epilepsy Drug Zonegran (zonisamide). Oct 14, 2013 1476
European Commission Approved Reinstatement of aprotinin/Trasylol Marketing Authorisations in European Union. Oct 10, 2013 433
CFDA Accepts Sihuan Pharmaceutical's Application for Clinical Trial Approval for Self-Developed Innovative Oncology Drug Pirotinib. Oct 10, 2013 544
Germany,United States : U.S. FDA Approves Bayer s Adempas(riociguat), the first soluble Guanylate Cyclase Stimulator, in Two Forms of Pulmonary Hypertension. Oct 10, 2013 438
Greece : THE European Commission approves of Aegean Airlines buyout of Olympic Air. Oct 10, 2013 141
MULTIMEDIA ASSETS NOW AVAILABLE: FDA Approves Bayer's New Class of Drug Adempas (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH. Oct 9, 2013 1898
Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray. Report Oct 9, 2013 1601
WE DON'T NEED A METHADONE FOR ALCOHOLICS; Treatment gets approval but bill for prescriptions could top PS200million a year DRUG FEARS OVER DRINK ABUSE PILL. Oct 8, 2013 525
Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies. Oct 8, 2013 2551
FDA Approves Bayer's New Class of Drug Adempas (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH. Oct 8, 2013 1885
Par Pharmaceutical Begins Shipment of Generic Kapvay. Oct 7, 2013 241
Canada : CANADIAN approval for fungal drug received by Valeant. Oct 5, 2013 224
United States : FDA approves Clinolipid for intravenous nutrition. Oct 5, 2013 442
Discovery Labs Announces FDA Approval of SURFAXIN (lucinactant) Updated Product Specifications. Oct 4, 2013 776
Valeant Pharmaceuticals Announces Approval Of Jublia For The Treatment Of Onychomycosis In Canada. Oct 3, 2013 1015
Eisai Receives European Commission Approval on Use of Antiepileptic Agent Zonegran in Pediatric Patients. Oct 3, 2013 478
Switzerland : FDA grants Roche s Perjeta accelerated approval for use before surgery in people with HER2-positive early stage breast cancer. Oct 3, 2013 437
Japan : Takeda and Lundbeck Announce FDA Approval of BrintellixTM (vortioxetine) for Treatment of Adults with Major Depressive Disorder. Oct 3, 2013 441
Data on Brisdelle(TM) (Paroxetine) Capsules, the First and Only FDA-Approved Non-Hormonal Therapy for Moderate to Severe Vasomotor Symptoms Associated with Menopause, to be Presented at the 2013 Annual Meeting of The North American Menopause Society. Oct 2, 2013 1862
FDA approves UCB's Cimzia for adults with active psoriatic arthritis. Oct 1, 2013 223
FDA-approved Facestock. Oct 1, 2013 145

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters